Maynard Um
-
-
-
-
-
-
-
Wolfe Research Starts Immunic Inc. (IMUX) at Outperform, PT $25
-
-
-
-
-
-
-
Immunic Inc. (IMUX) files for 458.15M share offering by selling stockholders
-
-
-
-
-
-
-
Roth/MKM Starts Immunic Inc. (IMUX) at Buy
-
-
-
-
-
-
-
Immunic Inc. (IMUX) Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Immunic Inc. (IMUX)
-
-
-
-
-
-
-
Immunic Inc. (IMUX) Presents Key Vidofludimus Calcium Data
-
-
-
-
-
-
-
B.Riley Starts Immunic Inc. (IMUX) at Buy
-
466,313 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


